128 related articles for article (PubMed ID: 3574424)
1. Effect of intervals between doses on the development of tolerance to isosorbide dinitrate.
Parker JO; Farrell B; Lahey KA; Moe G
N Engl J Med; 1987 Jun; 316(23):1440-4. PubMed ID: 3574424
[TBL] [Abstract][Full Text] [Related]
2. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
Kośmicki M; Szwed H; Kowalik I; Sadowski Z
Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
Kośmicki M; Sadowski Z
Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
[TBL] [Abstract][Full Text] [Related]
4. What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance?
Kośmicki M; Sadowski Z; Szwed H; Kowalik I
Med Sci Monit; 2000; 6(4):763-8. PubMed ID: 11208406
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of eccentric dosing with sustained-release isosorbide dinitrate in patients with angina pectoris.
Parker JO; Baird MG
Can J Cardiol; 1994 Nov; 10(9):909-12. PubMed ID: 7954026
[TBL] [Abstract][Full Text] [Related]
6. [Tolerance to a sustained release form of isosorbide dinitrate: comparison between 20 mg four times and 40 mg twice-daily administrations].
Hiasa Y; Hamai K; Wada T; Ootani R; Shinohara H; Aihara T; Bando M; Nakai Y; Kataoka Y
Kokyu To Junkan; 1991 Sep; 39(9):925-30. PubMed ID: 1749871
[TBL] [Abstract][Full Text] [Related]
7. Assessment of antianginal efficacy of long-acting sustained release isosorbide dinitrate in comparison with short-acting isosorbide dinitrate.
Rao YV; Reddy KS; Wasir HS
Indian Heart J; 1991; 43(2):97-100. PubMed ID: 1752623
[TBL] [Abstract][Full Text] [Related]
8. Nitrate tolerance.
Parker JO
Herz; 1984 Jun; 9(3):137-45. PubMed ID: 6430767
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation using serial exercise tests of verapamil alone and combined with isosorbide dinitrate in exertional angina].
Vázquez de Prada JA; Ruano J; Zueco J; Colman T; González-Vílchez F; Pajarón A
Rev Esp Cardiol; 1989 Oct; 42(8):513-8. PubMed ID: 2602607
[TBL] [Abstract][Full Text] [Related]
10. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of isosorbide dinitrate tape on exercise tolerance of patients with angina pectoris.
Saito M; Nobuyoshi M; Nakamura N; Nishiyama S; Haze K; Hiramori K; Ikeda M
Arzneimittelforschung; 1983; 33(9):1301-5. PubMed ID: 6685512
[TBL] [Abstract][Full Text] [Related]
12. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
Blasini R; Brügmann U; Reiniger G; Rudolph W
Herz; 1985 Jun; 10(3):163-71. PubMed ID: 3926613
[TBL] [Abstract][Full Text] [Related]
13. High-dosage isosorbide dinitrate therapy for angina.
Tremblay G; Biron P; Désourdy F
Can Med Assoc J; 1983 Mar; 128(6):679-81. PubMed ID: 6825033
[TBL] [Abstract][Full Text] [Related]
14. The daylong pattern of the antianginal effect of long-term three times daily administered isosorbide dinitrate.
Bassan MM
J Am Coll Cardiol; 1990 Oct; 16(4):936-40. PubMed ID: 2212374
[TBL] [Abstract][Full Text] [Related]
15. Clinical response and effects on left ventricular function of isosorbide dinitrate added to propranolol or diltiazem monotherapy in patients with chronic stable angina.
Humen DP; Kostuk WJ
Can J Cardiol; 1991 Mar; 7(2):74-80. PubMed ID: 2049686
[TBL] [Abstract][Full Text] [Related]
16. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy.
Thadani U; Fung HL; Darke AC; Parker JO
Am J Cardiol; 1982 Feb; 49(2):411-9. PubMed ID: 7058754
[TBL] [Abstract][Full Text] [Related]
17. [Dose-effect relationship of isosorbide dinitrate in the treatment of angina pectoris (author's transl)].
Schneider W; Stahl B; Kaltenbach M; Bussmann WD
Dtsch Med Wochenschr; 1982 May; 107(20):771-6. PubMed ID: 7075499
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test].
Rotrekl P; Vlasínová J; Manousek J; Semrád B; Rysavý F; Lupínek Z; Meluzín J; Vlasicová I; Pirochtová I; Bocek O
Vnitr Lek; 1993 Sep; 39(9):856-64. PubMed ID: 8212639
[TBL] [Abstract][Full Text] [Related]
19. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
[TBL] [Abstract][Full Text] [Related]
20. Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy.
Parker JO; VanKoughnett KA; Fung HL
Am J Cardiol; 1984 Jul; 54(1):8-13. PubMed ID: 6430057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
